169 related articles for article (PubMed ID: 28553295)
1. Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.
Shrestha R; Altice F; Karki P; Copenhaver M
Front Immunol; 2017; 8():561. PubMed ID: 28553295
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.
Shrestha R; Altice FL; Sibilio B; Ssenyonjo J; Copenhaver MM
Contemp Clin Trials; 2019 Jul; 82():77-84. PubMed ID: 31229618
[TBL] [Abstract][Full Text] [Related]
3. Adapting an Evidence-Based HIV Prevention Intervention Targeting High-Risk Migrant Workers: The Process and Outcome of Formative Research.
Shrestha R; Karki P; Pandey S; Copenhaver M
Front Public Health; 2016; 4():61. PubMed ID: 27066474
[TBL] [Abstract][Full Text] [Related]
4. A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development.
Glick JL; Zhang L; Rosen JG; Yaroshevich K; Atiba B; Pelaez D; Park JN
JMIR Form Res; 2023 Apr; 7():e42418. PubMed ID: 37052977
[TBL] [Abstract][Full Text] [Related]
5. Adapting an Evidence-Based Intervention Targeting HIV-Infected Prisoners in Malaysia.
Copenhaver MM; Tunku N; Ezeabogu I; Potrepka J; Zahari MM; Kamarulzaman A; Altice FL
AIDS Res Treat; 2011; 2011():131045. PubMed ID: 21860786
[TBL] [Abstract][Full Text] [Related]
6. Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention.
Copenhaver M; Chowdhury S; Altice FL
AIDS Patient Care STDS; 2009 Apr; 23(4):277-87. PubMed ID: 19260773
[TBL] [Abstract][Full Text] [Related]
7. Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.
Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M
J Assoc Nurses AIDS Care; 2017; 28(4):612-621. PubMed ID: 28478870
[TBL] [Abstract][Full Text] [Related]
8. Using Principles of an Adaptation Framework to Adapt a Transdiagnostic Psychotherapy for People With HIV to Improve Mental Health and HIV Treatment Engagement: Focus Groups and Formative Research Study.
Darnell D; Ranna-Stewart M; Psaros C; Filipowicz TR; Grimes L; Henderson S; Parman M; Gaddis K; Gaynes BN; Mugavero MJ; Dorsey S; Pence BW
JMIR Form Res; 2023 May; 7():e45106. PubMed ID: 37252786
[TBL] [Abstract][Full Text] [Related]
9. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
10. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.
Mugo NR; Ngure K; Kiragu M; Irungu E; Kilonzo N
Curr Opin HIV AIDS; 2016 Jan; 11(1):80-6. PubMed ID: 26575147
[TBL] [Abstract][Full Text] [Related]
11. Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.
Blashill AJ; Ehlinger PP; Mayer KH; Safren SA
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S187-90. PubMed ID: 25972502
[TBL] [Abstract][Full Text] [Related]
12. The role of healthcare providers in the roll out of preexposure prophylaxis.
Krakower DS; Mayer KH
Curr Opin HIV AIDS; 2016 Jan; 11(1):41-8. PubMed ID: 26417953
[TBL] [Abstract][Full Text] [Related]
13. A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.
Shrestha R; Krishnan A; Altice FL; Copenhaver M
Contemp Clin Trials; 2015 Sep; 44():95-102. PubMed ID: 26253181
[TBL] [Abstract][Full Text] [Related]
14. Using formative research to lay the foundation for community level HIV prevention efforts: an example from the AIDS Community Demonstration Projects.
Higgins DL; O'Reilly K; Tashima N; Crain C; Beeker C; Goldbaum G; Elifson CS; Galavotti C; Guenther-Grey C
Public Health Rep; 1996; 111 Suppl 1(Suppl 1):28-35. PubMed ID: 8862154
[TBL] [Abstract][Full Text] [Related]
15. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S; Krakower DS; Mayer KH
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the Field.
Batista P; Deren S; Banfield A; Silva E; Cruz M; Garnes P; Cleland CM; Mehandru S; LaMar M; Markowitz M
AIDS Patient Care STDS; 2016 Aug; 30(8):379-84. PubMed ID: 27509238
[TBL] [Abstract][Full Text] [Related]
17. Preexposure prophylaxis for the prevention of HIV transmission to women.
Aaron E; Cohan D
AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
[TBL] [Abstract][Full Text] [Related]
18. Adapting an evidence-based HIV behavioral intervention for South African couples.
Wechsberg WM; El-Bassel N; Carney T; Browne FA; Myers B; Zule WA
Subst Abuse Treat Prev Policy; 2015 Feb; 10():6. PubMed ID: 25888856
[TBL] [Abstract][Full Text] [Related]
19. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
20. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2012 Nov; 61(RR-5):1-40. PubMed ID: 23135062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
